In case you missed it, there was significant news this week on HIV treatment.
Federal health officials announced the results of a major international study that looked at how the timing of treatment affects patients' health.
The study found those who started HIV drugs early were far less likely to develop AIDS or other serious diseases.
MPR's Cathy Wurzer spoke with the principal investigator of that study, Jim Neaton, a professor of biostatistics at the University of Minnesota.
Your support matters.
You make MPR News possible. Individual donations are behind the clarity in coverage from our reporters across the state, stories that connect us, and conversations that provide perspectives. Help ensure MPR remains a resource that brings Minnesotans together.